フォロー
Joost Allard Offerhaus
Joost Allard Offerhaus
PhD, Amsterdam UMC
確認したメール アドレス: amsterdamumc.nl
タイトル
引用先
引用先
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
R Tadros, C Francis, X Xu, A Vermeer, AR Harper, R Huurman, ...
Nature genetics 53 (2), 128-134, 2021
2292021
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
J Barc, R Tadros, C Glinge, DY Chiang, M Jouni, F Simonet, SJ Jurgens, ...
Nature Genetics 54 (3), 232-239, 2022
992022
Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies
R Walsh, JA Offerhaus, R Tadros, CR Bezzina
Nature Reviews Cardiology, 1-17, 2021
872021
Epidemiology of inherited arrhythmias
JA Offerhaus, CR Bezzina, AAM Wilde
Nature Reviews Cardiology 17 (4), 205-215, 2020
662020
Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease–a cohort study across eighteen countries
A Uijl, A Schut, CEM Jakob, LR Romão, RM Bell, E McFarlane, M Stecher, ...
52*2021
Antihypertensive drugs in COVID-19 infection
SJ Pinto-Sietsma, M Flossdorf, VR Buchholz, J Offerhaus, H Bleijendaal, ...
European Heart Journal-Cardiovascular Pharmacotherapy 6 (6), 415-416, 2020
362020
Variant Intronic Enhancer Controls SCN10A-short Expression and Heart Conduction
JCK Man, FM Bosada, KT Scholman, JA Offerhaus, R Walsh, ...
Circulation 144 (3), 229-242, 2021
292021
Prophylactic (hydroxy) chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk
JA Offerhaus, AAM Wilde, CA Remme
Heart rhythm 17 (9), 1480-1486, 2020
282020
Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
European heart journal 43 (11), 1104-1120, 2022
182022
Sex-and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients
JA Offerhaus, LPT Joosten, M van Smeden, M Linschoten, H Bleijendaal, ...
IJC Heart & Vasculature 39, 100970, 2022
162022
Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning
RR van de Leur, H Bleijendaal, K Taha, T Mast, J Gho, M Linschoten, ...
Netherlands Heart Journal, 1-7, 2022
152022
High heart rate associated early repolarization causes J‐waves in both zebra finch and mouse
JA Offerhaus, PC Snelderwaard, S Algül, JW Faber, K Riebel, B Jensen, ...
Physiological reports 9 (5), e14775, 2021
92021
The ‘president’s drug’
AAM Wilde, JA Offerhaus
Netherlands Heart Journal 28 (7), 363-365, 2020
12020
NG2+ cells protect against cardiac remodeling and failure after myocardial infarction in mice
J Offerhaus, P Rainer, P Andersen, D Bedja, DI Lee, L Shenje, ...
Circulation 132 (suppl_3), A11820-A11820, 2015
12015
B-PO05-137 ARRHYTHMIC BURDEN AND THEIR PROGNOSTIC EFFECT ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS
J Offerhaus, LP Joosten, M van Smeden, HBF Rutten, GJ Geersing, ...
Heart Rhythm 18 (8), S427-S428, 2021
2021
COVID-19 does not only disturb our social rhythm
AAM Wilde, JA Offerhaus
Heart rhythm 18 (4), 510, 2021
2021
Membrin/GOSR2 is a novel NaV1. 5-interacting protein modulating cardiac conduction
J Offerhaus, S Podliesna, AO Verkerk, G Marchal, LE Lodder, ...
European Heart Journal 41 (Supplement_2), ehaa946. 3598, 2020
2020
The mechanism underlying J-waves and T-waves in the electrocardiogram of mice and zebra finches
JA Offerhaus, PC Snelderwaard, JW Faber, K Riebe, B Jensen, ...
bioRxiv, 2020
2020
Melatonin Blunts Pressure-overload Left Ventricular Hypertrophy and Improves Cardiac Performance in Pathologic and PPhysiologic Cardiac Hypertrophy
J Offerhaus, D Lee, D Bedja, O Cingolani
Circulation 132 (suppl_3), A19439-A19439, 2015
2015
Anti-hypertensive drugs possibly affect COVID-19 outcome through the double-edged sword ACE2
JA Offerhaus, CR Bezzina
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20